MUTATION‐BASED PRENATAL DIAGNOSIS OF HERLITZ JUNCTIONAL EPIDERMOLYSIS BULLOSA

Epidermolysis bullosa (EB) is a group of heritable diseases which manifest with blistering and erosions of the skin and mucous membranes. Due to life‐threatening complications and significant long‐term morbidity associated with the severe, neonatal lethal (Herlitz) form of junctional EB (H‐JEB), there has been a demand for prenatal diagnosis from families at risk for recurrence. Previously, the only reliable method of prenatal diagnosis of EB was a fetal skin biopsy performed at 16–20 weeks' gestation and analysed by electron microscopy. Recently, the genes LAMA3, LAMB3, and LAMC2, encoding the polypeptide subunits of laminin 5, an anchoring filament protein, have been shown to contain mutations in H‐JEB. In this study, direct detection of pathogenetic mutations in the laminin 5 genes was used to perform polymerase chain reaction (PCR)‐based prenatal testing. DNA was obtained by chorionic villus sampling (CVS) at 10–15 weeks or amniocentesis at 12–19 weeks' gestation in 15 families at risk for recurrence of JEB. In 13 cases, the fetus was predicted to be either genetically normal or a clinically unaffected carrier of a mutation in one allele. These predictions have been validated in all cases by the birth of a healthy child. In two cases, an affected fetus was predicted, and the diagnosis was confirmed by subsequent fetal skin biopsy. These results demonstrate that DNA‐based prenatal testing offers an early, expedient, and accurate method of prenatal diagnosis or an exclusion of Herlitz JEB. © 1997 by John Wiley & Sons, Ltd.

[1]  J. Uitto,et al.  A homozygous nonsense mutation in the PLEC1 gene in patients with epidermolysis bullosa simplex with muscular dystrophy. , 1996, The Journal of clinical investigation.

[2]  H. Shimizu,et al.  Homozygous deletion mutations in the plectin gene (PLEC1) in patients with epidermolysis bullosa simplex associated with late-onset muscular dystrophy. , 1996, Human molecular genetics.

[3]  E. Lane,et al.  Plectin deficiency results in muscular dystrophy with epidermolysis bullosa , 1996, Nature Genetics.

[4]  E. Lane,et al.  Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. , 1996, Genes & development.

[5]  J. Uitto,et al.  A recurrent homozygous nonsense mutation within the LAMA3 gene as a cause of Herlitz junctional epidermolysis bullosa in patients of Pakistani ancestry: evidence for a founder effect. , 1996, The Journal of investigative dermatology.

[6]  J. Uitto,et al.  A homozygous deletion mutation in the gene encoding the 180-kDa bullous pemphigoid antigen (BPAG2) in a family with generalized atrophic benign epidermolysis bullosa. , 1996, The Journal of investigative dermatology.

[7]  J. Uitto,et al.  Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa. , 1996, Human molecular genetics.

[8]  J. Uitto,et al.  Molecular complexity of the cutaneous basement membrane zone , 1996, Experimental dermatology.

[9]  R. Burgeson,et al.  Prenatal diagnosis of herlitz junctional epidermolysis bullosa by amniocentesis , 1995, Prenatal diagnosis.

[10]  C. Rodeck,et al.  A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in Herlitz junctional epidermolysis bullosa: prenatal exclusion in a fetus at risk. , 1995, Genomics.

[11]  J. R. McMillan,et al.  Mutations in the 180–kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa , 1995, Nature Genetics.

[12]  C. Rodeck,et al.  Genetic basis of lethal junctional epidermolysis bullosa in an affected fetus: Implications for prenatal diagnosis in one family , 1995, Prenatal diagnosis.

[13]  J. Uitto,et al.  Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia , 1995, Nature Genetics.

[14]  J. R. McMillan,et al.  A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. , 1995, Human molecular genetics.

[15]  J. Uitto,et al.  Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. , 1995, The Journal of investigative dermatology.

[16]  R. Burgeson,et al.  Identification of a homozygous one-basepair deletion in exon 14 of the LAMB3 gene in a patient with Herlitz junctional epidermolysis bullosa and prenatal diagnosis in a family at risk for recurrence. , 1995, The Journal of investigative dermatology.

[17]  K. Tryggvason,et al.  Identification of a homozygous exon-skipping mutation in the LAMC2 gene in a patient with Herlitz's junctional epidermolysis bullosa. , 1995, The Journal of investigative dermatology.

[18]  S. Peltz,et al.  Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon. , 1995, Genes & development.

[19]  R. Burgeson,et al.  A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. , 1994, Genomics.

[20]  J. Uitto,et al.  A novel homozygous nonsense mutation in the LAMC2 gene in patients with the Herlitz junctional epidermolysis bullosa. , 1994, Human molecular genetics.

[21]  J. Sanes,et al.  A new nomenclature for the laminins. , 1994, Matrix biology : journal of the International Society for Matrix Biology.

[22]  J. Uitto,et al.  Mutations in the γ2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa , 1994, Nature Genetics.

[23]  J. Uitto,et al.  Herlitz's junctional epidermolysis bullosa is linked to mutations in the gene (LAMC2) for the γ2 subunit of nicein/kalinin (LAMININ–5) , 1994, Nature Genetics.

[24]  J. Ortonne,et al.  Herlitz junctional epidermolysis bullosa keratinocytes display heterogeneous defects of nicein/kalinin gene expression. , 1994, The Journal of clinical investigation.

[25]  L. Smith,et al.  Ultrastructural findings in epidermolysis bullosa. , 1993, Archives of dermatology.

[26]  J. Ortonne,et al.  Nicein (BM-600) in junctional epidermolysis bullosa: polyclonal antibodies provide new clues for pathogenic role. , 1993, The Journal of investigative dermatology.

[27]  K. Will,et al.  Alternative splicing in the first nucleotide binding fold of CFTR. , 1993, Human molecular genetics.

[28]  D. Cooper,et al.  Human gene mutations affecting RNA processing and translation. , 1993, Annals of medicine.

[29]  R. Burgeson,et al.  Kalinin is abnormally expressed in epithelial basement membranes of Herlitz's junctional epidermolysis bullosa patients , 1992, Experimental dermatology.

[30]  R. Burgeson,et al.  Kalinin: an epithelium-specific basement membrane adhesion molecule that is a component of anchoring filaments , 1991, The Journal of cell biology.

[31]  J. Ortonne,et al.  GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study. , 1990, Journal of the American Academy of Dermatology.

[32]  J. Ortonne,et al.  The new basement membrane antigen recognized by the monoclonal antibody GB3 is a large size glycoprotein: modulation of its expression by retinoic acid. , 1988, Biochimica et biophysica acta.

[33]  C. Rodeck,et al.  Rapid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody , 1987, The British journal of dermatology.

[34]  H. Shimizu,et al.  Prenatal Diagnosis for Recessive Dystrophic Epidermolysis Bullosa in 10 Families by Mutation and Haplotype Analysis in the Type VII Collagen Gene (COL7A1) , 1996, Molecular medicine.

[35]  J. Uitto,et al.  Molecular diagnosis of inherited skin diseases: the paradigm of dystrophic epidermolysis bullosa. , 1996, Advances in dermatology.

[36]  J. Uitto,et al.  Detection of sequence variants in the gene encoding the β3 chain of laminin 5 (LAMB3) , 1995, Human mutation.

[37]  A. Lin,et al.  Epidermolysis bullosa : basic and clinical aspects , 1992 .

[38]  E. Bauer,et al.  Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. , 1991, Journal of the American Academy of Dermatology.

[39]  J. Ortonne,et al.  Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. , 1991, Laboratory investigation; a journal of technical methods and pathology.